\documentclass[11pt]{scrartcl}

\usepackage[margin=3.0cm]{geometry}                % See geometry.pdf to learn the layout options. There are lots.


% arguments:
\usepackage[square,comma,numbers,sort&compress]{natbib}
% arguments: opening/closing bracket, separator between multiple citations
% citation style: ‘ n’ for numerical style, ‘s’ for numerical superscript style,
% or ‘a’ for author–yearstyle
% punctuation between the author names and the year
% punctuation between years or numbers when common author lists are suppressed:
% ‘,’ or ‘;'

\bibpunct{}{}{,}{a}{}{;}


\geometry{letterpaper}                   % ... or a4paper or a5paper or ...
%\geometry{landscape}                % Activate for for rotated page geometry
%\usepackage[parfill]{parskip}    % Activate to begin paragraphs with an empty line rather than an indent
\usepackage{graphicx}
\usepackage{amssymb}
\usepackage{amsmath}
\usepackage{epstopdf}
\usepackage{verbatim}
\usepackage{rotating}
\usepackage{booktabs}
\usepackage{makecell}

\renewcommand\theadalign{bc}
\renewcommand\theadfont{\bfseries}
\renewcommand\theadgape{\Gape[2pt]}
\renewcommand\cellgape{\Gape[2pt]}


\def\etal{\emph{et al.}\,}

\usepackage[colorlinks = true,
            linkcolor = blue,
            urlcolor  = blue,
            citecolor = blue,
            anchorcolor = blue
            ]{hyperref}



\DeclareGraphicsRule{.tif}{png}{.png}{`convert #1 `dirname #1`/`basename #1 .tif`.png}

%\title{A  structural  map of disease mutations in GNAO1 protein}
%\subtitle{From molecular to physiological impact}
%\title{Rational dissection of GNAO1-related phenotypes using molecular modeling}

\title{Molecular map of GNAO1-related disease phenotypes and reactions to treatment}
\subtitle{Supplementary Information}
\author{Ivana Mihalek, Meredith Park, McKenna Kelly, Saima Kayani, \\ Jeff L. Waugh, Annapurna Poduri, and Olaf Bodamer}

\begin{document}
\maketitle


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%    Table S2
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
\subsection{Shorthands}

 The reference numbers refer to the list in this document, rather than in the main text. Shorthands:
E: epilepsy-related symptoms. MD: movement disorder-related symptoms

IF: interface. KD: ketogenic diet.  GTCs: generalized tonic-clonic seizures. NTR: neurotransmitter release.  NE: neuronal excitability, GEF: guanine nucleotide exchange factor.

For the shorthands used in square brackets, see above.

For the medication discussion and full list of in|effective medication see the original reference (where applicable).
\clearpage

\subsection{Table of variants}
\textbf{Table S2.} Variants, phenotypes and treatments.
The reaction to treatment in most cases indicates the trend, rather than the (in)ability of the drug to completely resolve the symptoms.
'No effect' sometimes includes exacerbation of the existing symptoms.
\newcounter{CaseNo}
% 1 - 10
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
	&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
	&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
	&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
	\hline
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
	\hline
		\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum} &F	&  E
		& \makecell[l]{no effect: \\ oxcarbazepine\\ levetiracetam\\ |effective: \\ phenobarbital \\ clobazam}
		& \makecell[l]{GABA$_A\uparrow$\\VGCC$\downarrow$\\NTR$\downarrow$}	&p.G40W	  & \makecell[l]{catalytic pocket}	&catalysis	&focal epilepsy	&	\\

	\hline
		\stepcounter{CaseNo} \arabic{CaseNo}  &\cite{law2015clinical}  & F	& MD+E	& not reported	&n/a	&p.G40R
			& catalytic pocket 	& catalysis	&EOEE	 & \makecell[l]{bilateral\\ twitching\\ in upper \\ limbs}\\

	\hline
		\stepcounter{CaseNo} \arabic{CaseNo} & \cite{bruun2018prospective} &M	&  E	& not reported
			& n/a	&p.G40R	 & \makecell[l]{catalytic pocket}	& catalysis	& EOEE	&	\\

	\hline
        \stepcounter{CaseNo} \arabic{CaseNo}  & \cite{kelly2019spectrum}  & M	&E
        &\makecell[l]{no effect: \\ levetiracetam\\ |effective:\\ topiramate \\ phenobarbital\\ clobazam} & \makecell[l]{GABA$_A\uparrow$\\VGCC$\downarrow$\\VGSC$\downarrow$\\NTR$\downarrow$}	 &p.G40R
        & catalytic pocket	& catalysis	&EOEE	& \\

	\hline
         \stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  & M	&MD+E	&\makecell[l]{|effective:\\levetiracetam_E}
         & \makecell[l]{NTR $\downarrow$}	 &p.G40E
         & catalytic pocket	&catalysis	&EOEE	&spastic quad \\

	\hline
        \stepcounter{CaseNo} \arabic{CaseNo}  & \cite{kelly2019spectrum}  & F	&MD+E
        &\makecell[l]{|effective:\\levetiracetam_E}	& \makecell[l]{NTR $\downarrow$}
        &p.G40E	& catalytic pocket	&catalysis	&EOEE	&\makecell[l]{dystonia\\spasticity} \\
\hline
\end{tabular}
\end{sidewaystable}


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
% 11-18
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
    \stepcounter{CaseNo} \arabic{CaseNo}  & \cite{zhu2015whole}  & M &MD+E & not reported & n/a   &p.G42R&  cat pocket & catalysis &  EOEE & choreoathetosis\\
\hline
    \stepcounter{CaseNo} \arabic{CaseNo}  & \cite{gawlinski2016peho}  &	F &E	&not reported	&n/a	&p.G45E	&RGS interface 	&catalysis	&EOEE	&\\
\hline
    \stepcounter{CaseNo} \arabic{CaseNo} & \cite{danti2017gnao1}  & M	&MD+E	&\makecell[l]{effective:\\tetrabenazine_MD}
	& \makecell[l]{NTR$\downarrow$} &p.S47G & ion binding	& catalysis	&focal seizures	&dystonia\\
\hline
    \stepcounter{CaseNo} \arabic{CaseNo} & \cite{danti2017gnao1}  & F	&MD+E	&not reported	&n/a&p.I56T	&IF btw domains	& \makecell[l]{improper\\opening/closing \\ of helix domain?}
    &focal seizures	&\makecell[l]{dyskinetic\\tongue movements; \\upper limb\\dyskinesia}\\
\hline


\hline
     \stepcounter{CaseNo} \arabic{CaseNo}  &  \cite{nakamura2013novo}  & F	&E	&not reported	&n/a	&p.D174G
     &\makecell[l]{helix;\\inward pointing\\sidechain \\ $<10\AA$ \\ from cat. pocket}	&catalysis (?)	&EE	&\\

\hline
      \stepcounter{CaseNo} \arabic{CaseNo} & \cite{marce2016gnao1}  & F	& MD+E
      &\makecell[l]{no effect:phenobarbital_E, valproate_E, levetiracetam_E,
vigabatrin_E, carbamazepine_E, zonisamide_E, clobazam_E, topiramate_E lacosamide_E hydroaltesone_E }
         & NE $\downarrow$	&p.L199P
        &	&catalysis	&EOEE	&\makecell[l]{orolingual\\ dyskinesia}\\

 \hline


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
 \hline
\end{tabular}
\end{sidewaystable}



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
% 11-18
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
%%%%%%%%%%%%%%%%%%%%%%%%%

\hline
	\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{arya2017gnao1}  & M	&MD+E
	&\makecell[l]{no effect:zonisamide_E\\ |effective: clobazam_E,  clonazepam_MD}
	& \makecell[l]{VGSC$\downarrow$\\ VGCC$\downarrow$\\ NE$\downarrow$ \\GABA$_A\uparrow$}	& p.G203R
	& \makecell[l]{close to \\salt-bridge\\ and cat pocket\\ Nakamura:\\ ddG for GTP  up}
	& empty pocket	&seizures	& chorea \\

\hline
	\stepcounter{CaseNo} \arabic{CaseNo}  & \citenum{nakamura2013novo}  & F	& MD+E	&not reported	&n/a	&p.G203R
	& &empty pocket	&EOEE	&\makecell[l]{severe\\ choreoathetosis}\\

\hline
	\stepcounter{CaseNo} \arabic{CaseNo} & \cite{saitsu2016phenotypic}  & F	& MD+E	&not reported	&n/a	&p.G203R
		&  & empty pocket  &EOEE	&severe chorea \\
\hline
    \stepcounter{CaseNo} \arabic{CaseNo} & \cite{schorling2017expanding}   & F & MD+E	&
        \makecell[l]{no effect: levodopa_E | effective:  sulthiame_E levetiracetam_E clobazam_E tiapride_E}
    & \makecell[l]{VGSC$\downarrow$\\ VGCC$\downarrow$\\ GABA$_A\uparrow$\\GABA$_B\uparrow$\\ ADCY$\downarrow$} 	&p.G203R
    &\ 	& empty pocket 	&\makecell[l]{severe epilepsy}	&\makecell[l]{severe dystonia}\\

\hline
    \stepcounter{CaseNo} \arabic{CaseNo} & \cite{schorling2017expanding}  & F & MD+E
     &\makecell[l]{no effect:  phenobarbital_E, levetiracetam_E, topiramate_E, valproate_E, vigabatrin_E,
     oxcarbazepine_E, phenytoin_E, clobazam_E, lacosamide_E, methylprednisolone_E gabapentin_MD  trihexyphenidyl_MD
     |effective: lamotrigine_E zonisamide_E baclofen_MD benzodiazepine_MD}
    &  \makecell[l]{NTR$\downarrow$\\ GABA$_A\uparrow$\\D2$\downarrow$; D3$\downarrow$} 	&p.G203R
    & 	& empty pocket 	&\makecell[l]{severe epilepsy}	&\makecell[l]{severe dystonia}\\


\hline
    \stepcounter{CaseNo} \arabic{CaseNo} 	 & \cite{schirinzi2018phenomenology}  &F	&MD+E
    &  \makecell[l]{no effect: phenobarbital_E, carbamazepine_E , benzodiazepine_E |effective: topiramate_E clonazepam_MD}
    & \makecell[l]{VGSC$\downarrow$\\ GABA$_A\uparrow$} 	&p.G203R
    &  & empty pocket  & EOEE	& \makecell[l]{dystonia; \\ paroxysmal\\ ballism;\\ chorea} \\

\hline
    \stepcounter{CaseNo} \arabic{CaseNo} 	 & \cite{schirinzi2018phenomenology}  &M	&MD+E
    &\makecell[l]{effective: tetrabenazine_MD \\ lorazepam_MD \\ baclofen_MD \\phenobarbital_E}
    & \makecell[l]{NTR$\downarrow$\\ GABA$_A\uparrow$ \\ VGCC$\downarrow$\\GABA$_B\uparrow$\\ ADCY$\downarrow$} 	&p.G203R
    &  & empty pocket  & EOEE	&  \makecell[l]{ 4 limbs\\ dyskinesia;\\ chaotic \\spontaneous\\ motility} \\




\hline
    \stepcounter{CaseNo} \arabic{CaseNo} 	 & \cite{xiong2018recurrent}  &F	&MD+E
    & \makecell[l]{no effect: valproate_E|effective: topiramate_E levetiracetam_E vigabatrin_E}
    & \makecell[l]{NTR$\downarrow$\\ GABA$_A\uparrow$ \\ VGSC$\downarrow$ } 	&p.G203R
    &  & empty pocket  & EOEE	&  \makecell[l]{lack of \\ psychomotor\\ development} \\



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
		\hline
\end{tabular}
\end{sidewaystable}


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
% 11-18
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
		%%%%%%%%%%%%%%%%%%%%%%%%%

%%%%%%%%%% patient 2
 \hline
 \stepcounter{CaseNo} \arabic{CaseNo} 	 & \cite{koy2018deep}  &M	&MD+E
 & \makecell[l]{|effective: \\ levodopa_MD,\\ tetrabenazine_MD benzodiazepine_MD}
 & \makecell[l]{dopamine$\uparrow$} 	&p.G204R
 &  & empty pocket  & EOEE	&  \makecell[l]{hypotonia;\\dystonic \\posturing;\\chorea;\\ballism } \\



\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}   & M & MD
& \makecell[l]{no effect: \\ sinemet \\ |effective: \\ botox }	&  mAChR$\downarrow$	&p.S207Y
& \makecell[l]{effector IF\\RGS IF}	& effector	&	&\makecell[l]{motor delays \\ generalized \\dystonia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{yamashita2020neuroimaging}   & F & MD
  & \makecell[l]{no effect: \\ levodopa \\  tetrabenazine \\ trihexyphenidyl \\ clonazepam \\
	botox \\ pramipexole}	&  	&p.S207F
& \makecell[l]{effector IF\\RGS IF}	& effector	&	&\makecell[l]{choreoathetosis\\dystonia\\bradykinesia}\\

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
\end{tabular}
\end{sidewaystable}



\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
		\hline

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{kelly2019spectrum}  & F	& (unclear)	&	&	&p.R209C
& salt bridge	&effector	&	& \makecell[l]{(?)\\hypotonia}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  &	\cite{danti2017gnao1}  &M &MD+E	&not reported	&n/a	&p.R209C
& salt bridge	& effector		&GTCs	&hyperkinetic\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  &\cite{danti2017gnao1}  &M	&MD+E	&not reported	&n/a	&p.R209C
& salt bridge 	& effector 	&\makecell[l]{focal\\seizures}
& \makecell[l]{complex\\ stereotypies;\\ dyskinetic \\motor pattern}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} & 	\cite{saitsu2016phenotypic}  & F&MD+E	&not reported	&n/a	&p.R209C
& salt bridge	& effector	&\makecell[l]{focal\\dyscognitive\\ seizures}	&severe chorea\\

%%% patient 3
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{waak2017gnao1}  &  F& MD+E
&\makecell[l]{no effect: \\midazolam_MD |effective:\\ clonidine_MD benzhexol_MD }
& \makecell[l]{ADRA$\uparrow$\\ADCY$\downarrow$}	&p.R209C
&  salt bridge	& effector	& GTCs	&\makecell[l]{chorea; \\dystonia;\\ ballism;\\ oro-facio-lingual\\dyskinesia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{malaquias2019gnao1}  &F	&MD
& \makecell[l]{no effect:\\ clonazepam \\ trihexyphenidyl\\ |effective: levodopa}  &dopamine$\uparrow$	&p.R209C
&salt bridge	&effector	&  &\makecell[l]{hyperkinetic\\movements;\\generalized\\disabling tremor}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{honey2018gnao1}  &M	&MD
& \makecell[l]{no effect:\\chlorpromazine \\ |effective: levodopa \\ clonazepam \\ bromocriptine}
&\makecell[l]{dopamine$\uparrow$\\GABA$_A\uparrow$ \\D2$\uparrow$, ADCY$\downarrow$}	&p.R209C
&salt bridge	&effector	&  &\makecell[l]{dystonic storm;\\chorea, ballismus,\\ orofacial\\dyskinesia,\\dystonia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{koy2018deep}  &F	&MD
& \makecell[l]{no effect: tetrabenazine\\ trihexyphenidyl\\ levodopa}
& \makecell[l]{}	&p.R209C
&salt bridge	&effector	&  &\makecell[l]{dystona w\\ hyperkinetic\\features;\\ orofacial\\dyskinesia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{koy2018deep}  &M	&MD+E
& \makecell[l]{no effect: levetiracetam_E  baclofen_MD  botox_MD  trihexyphenidyl_MD
    \\ | effective: valproate_E  topiramate_E  lamotrigine_E  tetrabenazine_MD}
&\makecell[l]{}	&p.R209C
&salt bridge	&effector	& \makecell[l]{tonic-clonic and \\ partial\\complex\\frontal\\seizures} &\makecell[l]{decreased\\muscle tone,\\dystonia,\\athetosis}\\

%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{schirinzi2018phenomenology}  &F	&MD
& \makecell[l]{no effect: midazolam, propofol, phenytoin, baclofen, clonazepam, levodopa, tetrabenazine, clonidine
|effective: haloperidol, curare}
&\makecell[l]{}	&p.R209C
&salt bridge	&effector
&  trunk hypotonia; generalized choreo-ballistic hyperkinesia}\\




%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline


\end{tabular}
\end{sidewaystable}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
%19-27
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  &\cite{ananth2016clinical}  &	F&MD
& {\scriptsize \makecell[l]{no effect:\\clonidine, \\valproate, \\clonazepam, \\bethanechol; \\ |effective: \\dexmedetomidine, \\ propofol,  midazolam}}
& \makecell[l]{ADRA$\uparrow$ \\ ADCY$\downarrow$ \\GABA$_A\uparrow$ }
 &p.R209G
&salt bridge	&effector	&	&chorea\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{ananth2016clinical}  &M	&MD
&{\scriptsize \makecell[l]{effective: dexmedetomidine, \\benzodiazepine \\risperidone.}}
& \makecell[l]{D2$\downarrow$ 5-HT2$\downarrow$\\dopamine$\uparrow$ \\ ADRA$\uparrow$ \\ ADCY$\downarrow$ \\GABA$_A\uparrow$ }	&p.R209H
&salt bridge	&effector	&	&\makecell[l]{chorea and\\ ballismus}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} &  \cite{dhamija2016gnao1}  &	M &  MD
& \makecell[l]{\\ tetrabenazine\\\\trihexyphenidyl}
& \makecell[l]{NTR$\downarrow$ \\ mAChR$\uparrow$\\ D1$\uparrow$  D2$\downarrow$\\dopamine$\uparrow$}	&  p.R209H
&salt bridge	&effector	&	&\makecell[l]{dystonia;\\severe chorea}\\

\hline
 \stepcounter{CaseNo} \arabic{CaseNo} & \cite{kulkarni2016progressive}  &M	&MD
 &{\scriptsize \makecell[l]{no effect:\\ clonazepam \\ |effective:\\  'valproate'}}
& GABA $\uparrow$ (?)
&p.R209H	&salt bridge	&effector	&	&severe choreathetosis\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{kulkarni2016progressive}  &	M	&MD	&\makecell[l]{|effective: clonazepam}	&na	&p.R209H
&salt bridge	&effector	&	&severe choreathetosis\\

\hline
 \stepcounter{CaseNo} \arabic{CaseNo} & \cite{menke2016recurrent}  &M	&MD	&not reported	&n/a	&p.R209H
 &salt bridge	&effector	&
&\makecell[l]{mobile dystonia\\ with myoclonic jerks}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{menke2016recurrent}  &M	&MD	&not reported	&n/a	&p.R209L
&salt bridge	&effector	&	 &\makecell[l]{mobile dystonia\\ with myoclonic jerks}\\



\hline
	\end{tabular}
\end{sidewaystable}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
%28 - 26
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  &	F&MD 	& levodopa	& dopamine $\uparrow$	&p.A221D
&\makecell[l]{close to\\ Cterm helix} &\makecell[l]{GPCR\\ (GEF)}	&	&\makecell[l]{dysarthia,\\dystonia,\\ tremor and\\ parkinsonsim}\\

\hline
 \stepcounter{CaseNo} \arabic{CaseNo} &  \cite{saitsu2016phenotypic}  &F	&MD+E
 &	\makecell[l]{no effect: valproate_E  clonazepam_E  \\ |effective:  prednisone_E}

 &  GCR$\downarrow$ %\makecell[l]{refractory to \\anti-epileptic \\drugs}
 &p.A227V	&\makecell[l]{2nd row to\\ catalytic pocket}	& \makecell[l]{catalysis\\(folding?)}
 &\makecell[l]{EOEE\\(infantile\\spasms)}
 &\makecell[l]{hand \\ stereotypies}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{talvik2015clinical}  &F	&MD+E
&\makecell[l]{no effect:  \\phenobarbitone_E, \\vigabatrine_E,  \\lamotrigine_E.}
	&	&p.Y231C	&cryptic	&	&EOEE	&\makecell[l]{stereotypic\\ spasm-like \\movements}\\
		\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{yilmaz2016excellent}  &F &MD
&\makecell[l]{no effect: KD |effective:\\  midazolam;\\ fentanyl; \\pimozide.}
& \makecell[l]{GABA$_A\uparrow$;\\ OPRM1$\uparrow$\\ ADCY$\downarrow$;\\ VGCC$\downarrow$; \\ NTR$\downarrow$; D2$\downarrow$; \\ ADRA$\downarrow$; \\5-HT2$\downarrow$}
& p.Q233P
& \makecell[l]{IF with \\helical domain\\ when closed}	&	&	&\makecell[l]{choreathetosis \\and orofacial\\ dyskinesia}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{waak2017gnao1}   &M &MD
&{\scriptsize  \makecell[l]{no effect: levodopa \\diazepam, clobazam, \\
		benzhexol, clonidine,\\ prednisolone,  baclofen, \\ dexmedetomidine,\\ midazolam, ketamine \\
		|effective: botox clonazepam\\ phenobarbital\\ tetrabenazine }}
&  \makecell[l]{ GABA$_A\uparrow$ (?)\\ VGCC$\downarrow$; \\NTR$\downarrow$ }	& p.E237K
		& \makecell[l]{effector IF (?)}	& \makecell[l]{effector IF\\RGS IF}	&	&\makecell[l]{chorea; \\ hemiballism;\\dystonia;\\ oro-facio-lingual\\dyskinesia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{okumura2018patient}   &F &MD	& not reported
&  	& p.E237K
& \makecell[l]{effector IF (?)}	& \makecell[l]{effector IF\\RGS IF}	&	&\makecell[l]{hypotonia; \\dystonic \\ features.}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{koy2018deep}  &M	&MD
& \makecell[l]{not reported}
&\makecell[l]{}	&p.E237K
&	& &	& \makecell[l]{severe\\hypotonia;\\ballism;\\dystonia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{koy2018deep}  &M	&MD
& \scriptsize{\makecell[l]{no effect:clonazepam,\\ trihexyphenidyl,\\ tetrabenazine,\\ amitriptyline,\\ pimozide}}
&\makecell[l]{}	&p.E237K
&	& &	& \makecell[l]{dystonic and \\dyskinetic \\features; chorea} \\


%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{schirinzi2018phenomenology}  &F	&MD
&
&\makecell[l]{}	&p.E237K
&	& &	& global hypotonia;  choreiform and dyskinetic movements \\





%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
	\end{tabular}
\end{sidewaystable}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{ananth2016clinical}  &M	&MD	&\makecell[l]{intermittent \\chorea not treated}	&	&p.E246K
	&salt bridge	& effector	&	 &\makecell[l]{chorea \\and \\ballismus}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{ananth2016clinical}   & F &MD
&\tiny{\makecell[l]{no effect: clonazepam\\clonidine and trazodone; \\|effective: tetrabenazine.}}
& VMAT2$\downarrow$; NTR$\downarrow$ &p.E246K
& salt bridge	& effector	&	&\makecell[l]{chorea \\and \\ballismus} \\
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{ananth2016clinical}  & F &MD	&
\tiny{\makecell[l]{no effect: topiramate, \\levetiracetam, \\valproate \\and clonidine.\\
		 |effective:\\ clonazepam \\and clobazam. \\
		effective: \\ baclofen  clobazam \\ tetrabenazine \\ haloperidol  diazepam  diazepam.}}
    	&  \makecell[l]{ GABA$_B\uparrow$; \\ADCY$\downarrow$\\ VMAT2$\downarrow$; NTR$\downarrow$\\ D2$\downarrow$;  ADRA$\downarrow$;\\ 5-HT2$\downarrow$}
		& p.E246K
	    & salt bridge	& effector	&	&\makecell[l]{chorea \\and \\ballismus}\\
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{ananth2016clinical}  & M	&MD	&\makecell[l]{no effect: \\oxcarbazepine \\and clonazepam.\\
	|effective: \\diazepam and \\tetrabenazine.}
& \makecell[l]{GABA$_A\uparrow$\\VMAT2$\downarrow$; NTR$\downarrow$}		& p.E246K
	&  salt bridge &  effector	&	&\makecell[l]{mild \\dyskinesia first, \\then generalized \\chorea}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{waak2017gnao1}  &  F&MD
&{\tiny \makecell[l]{no effect:levodopa;  clobazam; clonidine\\ benzhexol, carbamazepine, \\
	nitrazepam, lorazepam, \\
	acetazolamide, biotin, \\
	botox, \\
	prednisolone, immunoglobulin, \\ midazolam   \\
	 |effective:\\ tetrabenazine \\ phenobarbital  }}
& \makecell[l]{VMAT2$\downarrow$; NTR$\downarrow$\\ GABA$_A\uparrow$\\VGCC$\downarrow$; }
&p.E246K
& salt bridge 	& effector	& 	&\makecell[l]{chorea; \\dystonia;\\ hemiballism;\\ oro-facio-lingual\\dyskinesia}\\

\hline
\end{tabular}
\end{sidewaystable}



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
		\hline
		&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
		&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
		&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline

%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{saitsu2016phenotypic}  &F &MD	&not reported	&n/a	&p.E246K
& salt bridge 	& effector		&	&severe athetosis\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{takezawa2018genomic}  &	F &	 MD
& not reported
& n/a	&p.E246K
	& salt bridge	& effector		& 	&\makecell[l]{dyskinesia,\\ global \\ developmental delays}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{schorling2017expanding}  & M &	MD
&	\makecell[l]{no effect: levodopa;\\   |effective:\\ not reported }
& n/a	&p.E246K
& salt bridge	&	effector	&\makecell[l]{}	&\makecell[l]{dystonia}\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{schorling2017expanding}   & F &	MD+E
&	\makecell[l]{ |effective:\\ oxcarbazepine_E\\ levetiracetam_E }
& \makecell[l]{	VGSC$\downarrow$\\NTR$\downarrow$} &p.E246K
&  salt bridge 	& effector	&\makecell[l]{epilepsy}	&\makecell[l]{}\\



\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{benato2019long}   &F &	MD
&{\tiny 	\makecell[l]{ no effect:\\ trihexyphenidyl\\ nitrazepam \\ clonazepam\\ tetrabenazine \\ baclofen\\ levodopa \\ levetiracetam \\ phenobarbital}}
&   &p.E246K
&  salt bridge 	& effector	&\makecell[l]{}	&\makecell[l]{dystonia\\ chorea\\ ballismus\\hyperkynesia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{benato2019long}   &F &	MD
&{\tiny 	\makecell[l]{no effect: \\ baclofen \\ trihexyphenidyl\\ tetrabenazine\\ pimozide  \\|effective:\\ flunitrazepam}}
& \makecell[l]{GABA$_A\uparrow$	} &p.E246K
&  salt bridge 	& effector	&\makecell[l]{}	&\makecell[l]{hyperkinetic\\spells; \\ choreo-ballistic\\ movements; \\ dystonia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{danti2017gnao1}  &	M&MD+E
& effective: tetrabenazine_MD
& \makecell[l]{VMAT2$\downarrow$; NTR$\downarrow$}	&p.E246G
& salt bridge	& effector		&\makecell[l]{GTCs and \\focal seizures}	&\makecell[l]{dystonia,\\spasticity}\\


\hline
\end{tabular}
\end{sidewaystable}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage
%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\begin{sidewaystable}
	\centering
	\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
	\hline
&\thead{Ref}	&\thead{Sex}	& \thead{\makecell{Pheno}}	&\thead{Therapy}
&\thead{\makecell{Effective\\drug\\mechanism}}	& \thead{Variant}	& \thead{Location}
&\thead{\makecell{Impact\\estimate}} 	&\thead{E type} 	&\thead{MD type} \\
		\hline
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{appenzeller2014novo}  &F	&E	&not reported	&n/a	&p.A270H	&catalytic pocket	& catalysis	&EOEE	&\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{schirinzi2018phenomenology}  &F	&MD+E	&
{\scriptsize \makecell[l]{effective: \\ lamotrigine_E \\ + valproate_E  \\ + trihexyphenidyl_MD  \\ + melatonin_E  }}
& \makecell[l]{GABA$\uparrow$; \\VGSC$\downarrow$;\\ mAChR$\uparrow$; \\ D1$\uparrow$; D2$\downarrow$;\\ dopamine$\uparrow$;\\ ADCY$\downarrow$}	&p.D273V
&\makecell[l]{catalytic pocket}	& empty pocket	&EOEE	&
{\scriptsize \makecell[l]{poor head \\ and turn ctrl; \\ axial hypotonia;\\lower limbs\\hypertonia; \\spasticity}} \\



\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  &F	&MD+E	& levodopa_MD	&  dopamine $\uparrow$	&p.D273V
&\makecell[l]{catalytic pocket}	& empty pocket	&EOEE	&Dyskinesia\\
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{appenzeller2014novo}  &F	&E	&not reported	&n/a	& p.F275S
& cryptic	& 	&EOEE	&\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{nakamura2013novo}  &F	&E	&not reported	&n/a	&p.I279N	&cryptic	&	&EOEE	&\\

\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  &F	&MD+E	&not reported	&n/a	&p.I279N	&cryptic	&	&EOEE	& \makecell[l]{choreoathetoid \\movements, \\akathisia}\\


\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{gerald2018neonatal}  &F	&E
&{\scriptsize \makecell[l]{no effect:\\pyridoxine,\\
	levetiracetam, \\fosphenytoin, \\valproate, \\clobazam, \\zonisamide,\\
	rufinamide, \\prednisone, KD, \\ACTH, immunoglobulin}}
&	&p.L284S	&cryptic	&	&EOEE	& \\
%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo}  & \cite{kelly2019spectrum}  &F	&E	& lacosamide
& VGSC$\downarrow$	&p.Y291N	&cryptic	&	&EOEE	&\\
\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  &	F&\makecell[l]{MD,\\ MD+E}
& effective: trihexyphenidyl_MD
& \makecell[l]{mAChR$\uparrow$; \\ D1$\uparrow$; D2$\downarrow$;\\ dopamine$\uparrow$}
	&p.I344del	&C-term helix	& GPCR	&one seizure
&\makecell[l]{mild\\spasticity,\\ dystonia, \\chorea,\\ dysarthria}\\

%%%%%%%%%%%%%%%%%
\hline
\stepcounter{CaseNo} \arabic{CaseNo} & \cite{kelly2019spectrum}  &F &E	&levetiracetam	&	NTR$\downarrow$ &\makecell[l]{p.R349\\G352\\delinsQGCA}
&\makecell[l]{C-term helix}
&\makecell[l]{\textit{enhanced} \\opening of Ga}
& \makecell{atypical\\staring\\spells}	&\makecell{oromotor\\apraxia}\\
		\hline
	\end{tabular}
\end{sidewaystable}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\clearpage

% Bibliography
\bibliographystyle{pnas-new}
\bibliography{gnao}


\end{document}
